Steven Basta

Steven L.
Basta is President, Chief Executive Officer & Director at Phathom Pharmaceuticals, Inc. since 2025.
He is Chairman at Viveve, Inc. since 2019, Chairman at Illumisonics, Inc. since 2023, Director at DermBiont, Inc. since 2020, Independent Director at VYNE Therapeutics, Inc. since 2015, and Advisor at Spindletop Capital Management LLC.
Former roles include President & Chief Executive Officer at Gliatech, Inc. from 2000 to 2002, Chief Executive Officer at BioForm Medical, Inc. from 2002 to 2010, Chief Executive Officer at Merz Aesthetics, Inc. from 2010 to 2011, Chief Executive Officer at Lifeward CA, Inc. from 2011 to 2015, Chief Executive Officer at Altergo (New York) from 2011 to 2015, Director at RF Surgical Systems, Inc. from 2013 to 2015, President, Chief Executive Officer & Director at Menlo Therapeutics, Inc. from 2015 to 2020, Chief Executive Officer at Mahana Therapeutics, Inc. from 2020 to 2022, Chairman at Viveve Medical, Inc. from 2019 to 2023, Independent Director at Carbylan Therapeutics, Inc. from 2009 to 2016, Chief Financial Officer & VP-Business Development at Creative Biomolecules, Inc. from 1997 to 2000, Associate at Dillon, Read & Co., Inc., Chief Executive Officer at SaNOtize Research & Development Corp., and Executive Director-Product Development at Orchestra Therapeutics, Inc. Education includes undergraduate studies at The Johns Hopkins University and an MBA from Kellogg School of Management.